Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group

Department of Medicine, New York University School of Medicine, New York.

In the conservative strategy arm of phase II of the Thrombolysis in Myocardial Infarction (TIMI) trial, 1,461 patients were treated with intravenous recombinant tissue-type plasminogen activator (rt-PA). Coronary angiography, with angioplasty if feasible, was to be performed only for recurrent spontaneous or exercise-induced ischemia. In this study results in patients treated by this strategy in community and tertiary hospitals are compared. Despite similar baseline findings in the two groups, coronary angiography was performed within 42 days in more patients (542 [48%] of 1,155) initially admitted to a tertiary hospital (on-site coronary angiography/angioplasty available) than in those (94 [32%] of 306) admitted to a community hospital (transfer to tertiary hospital for coronary angiography/angioplasty) (p less than 0.001). This different approach resulted in a greater use of coronary angioplasty (203 [18%] of 1,155 versus 32 [11%] of 306, p less than 0.01), coronary artery bypass surgery (133 [12%] of 1,155 versus 23 [8%] of 306, p less than 0.05) and blood transfusions (139 [12%] of 1,155 versus 17 [5.5%] of 306, p less than 0.001) in patients admitted to a tertiary than to a community hospital. However, there were no significant differences between the two groups in mortality, recurrent myocardial infarction or left ventricular function. These results demonstrate that a conservative strategy after treatment of acute myocardial infarction with rt-PA is applicable in the community hospital setting.

This article has been cited by other articles:

				F. Van de Werf, J. M Gore, A. Avezum, D. C Gulba, S. G Goodman, A. Budaj, D. Brieger, K. White, K. A A Fox, K. A Eagle, et al. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study BMJ, February 26, 2005; 330(7489): 441. [Abstract] [Full Text] [PDF]

				G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction Heart, June 1, 2004; 90(6): e37 - e37. [Abstract] [Full Text] [PDF]

				D. A. Alter, J. V. Tu, P. C. Austin, and C. D. Naylor Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada J. Am. Coll. Cardiol., August 6, 2003; 42(3): 410 - 419. [Abstract] [Full Text] [PDF]

				R. H. Mehta, D. A. Criger, C. B. Granger, K. K. Pieper, R. M. Califf, E. J. Topol, and E. R. Bates Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1034 - 1040. [Abstract] [Full Text] [PDF]

				J Llevadot, R.P Giugliano, E.M Antman, R.G Wilcox, E.P Gurfinkel, T Henry, C.H McCabe, A Charlesworth, S Thompson, J.C Nicolau, et al. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction Eur. Heart J., November 2, 2001; 22(22): 2104 - 2115. [Abstract] [PDF]

				D. A. Alter, C. D. Naylor, P. C. Austin, and J. V. Tu Long-term MI Outcomes at Hospitals With or Without On-site Revascularization JAMA, April 25, 2001; 285(16): 2101 - 2108. [Abstract] [Full Text] [PDF]

				W. J. Rogers, J. G. Canto, H. V. Barron, J. A. Boscarino, D. A. Shoultz, N. R. Every, and for the Investigators in the National Registry of Treatment and outcome of myocardial infarction in hospitals with and without invasive capability J. Am. Coll. Cardiol., February 1, 2000; 35(2): 371 - 379. [Abstract] [Full Text] [PDF]

				S. Basu, R. Senior, U. Raval, and A. Lahiri Superiority of Nitrate-Enhanced 201Tl Over Conventional Redistribution 201Tl Imaging for Prognostic Evaluation After Myocardial Infarction and Thrombolysis Circulation, November 4, 1997; 96(9): 2932 - 2937. [Abstract] [Full Text]

				S. Basu, R. Senior, C. Dore, and A. Lahiri Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients BMJ, October 5, 1996; 313(7061): 844 - 848. [Abstract] [Full Text]

				S. Behar, H. Hod, B. Benari, R. Narinsky, H. Pauzner, E. Rechavia, H. E. Faibel, A. Katz, A. Roth, E. Goldhammer, et al. On-Site Catheterization Laboratory and Prognosis After Acute Myocardial Infarction Arch Intern Med, April 24, 1995; 155(8): 813 - 817. [Abstract] [PDF]

				G. I. Barbash, H. D. White, M. Modan, R. Diaz, J. R. Hampton, J. Heikkila, A. Kristinsson, S. Moulopoulos, E. A. C. Paolasso, T. Van der Werf, et al. Outcome of Thrombolytic Therapy in Relation to Hospital Size and Invasive Cardiac Services Arch Intern Med, October 10, 1994; 154(19): 2237 - 2242. [Abstract] [PDF]

				J. Blustein High-Technology Cardiac Procedures: The Impact of Service Availability on Service Use in New York State JAMA, July 21, 1993; 270(3): 344 - 349. [Abstract] [PDF]

				R. A. Lange and L. D. Hillis Immediate Angioplasty for Acute Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 726 - 728. [Full Text]

				R. J. Krone The Role of Risk Stratification in the Early Management of a Myocardial Infarction Ann Intern Med, February 1, 1992; 116(3): 223 - 237. [Abstract] [PDF]